DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	VGLL3; FOXE1; INHBA; WT1; HOXA6; HOXA11; HOXA13; HOXC12; HOXD11; HOXD12; IRX4; EVX2; LBX2; ATOH7; ISL2; DMRTA2; PITX2; VGLL1; FOXA2; DLX2; FOXD3; EGR4; EMX2; SP9; FOXC2; ZIC5; FOXL2; SP8; ZIC2; DLX6; FOXI3; ASCL5; DUX4L9; EN1; MYT1; EN2; BATF3; FOXL1; TCF15; NR2E1; FOXD1; FOSL1; RXRG; FOXQ1; VAX1; DLX5; DLX1; VAX2;	GO:0006357~regulation of transcription by RNA polymerase II	48	747	6.42570281124498	0	0	0	0	0	0	0
down	FOXE1; PAX7; HOXA11; HOXC13; LHX1; EN1; FAT1; SIX2; SIX4; FOXL2; FOXQ1; SOX11; SOX1; FOXC2; FOXL1; PITX2; FOXD3; FOXI3; FOXD1; PITX3; FOXA2;	GO:0009653~anatomical structure morphogenesis	21	127	16.5354330708661	0	0	0	0	0	0	0
down	HOXC11; GLI2; HOXB8; HOXD10; MSX1; HOXA10; HOXA11; HOXC8; HOXC13; HOXD13; LHX1; EMX2; ALX1; CYP26C1; ALX4; HOXC10; HOXA6; HOXD9; HOXC9; HES7;	GO:0009952~anterior/posterior pattern specification	20	99	20.2020202020202	0	0	0	0	0	0	0
down	LCE6A; LCE2B; KRT34; KRT75; KRT16; KRTAP2-3; CDH3; CASP14; KRT76; DSG2; LCE3E; LCE1C; LCE1D; LCE1E; LCE1F; LCE1B; LCE3A; LCE2A; LCE2C; LCE2D; KRT27; DSG4; KRTAP19-1; PKP2; KRTAP4-1; KRTAP3-1; KRT84; KRT82;	GO:0031424~keratinization	28	181	15.4696132596685	0	0	0	0	0	0	0
down	KRT34; KRT75; KRT16; CASP14; SPRR2B; KRT76; DSG2; LCE1A; LIPN; LIPM; SPINK6; RPTN; KRT27; DSG4; PKP2; LCE3D; SPRR2G; KRT84; KRT82; KLK5;	GO:0070268~cornification	20	113	17.6991150442478	0	0	0	0	0	0	0
down	ST8SIA3; ST8SIA6; B4GALNT1; ST6GALNAC5;	GO:0001574~ganglioside biosynthetic process	4	11	36.3636363636364	0.00010143552295938	0.00515517868906899	0.227519877997892	0.231983041008105	0.210275839094797	0.227519877997892	0.042852064413384
down	KCNK2; FOSL1; TNC; GATA4; P2RY1; POSTN; SOST;	GO:0009612~response to mechanical stimulus	7	57	12.280701754386	0.00011440252053596	0.00545080342636965	0.256490451041625	0.261638564465743	0.228179447281712	0.256261646000553	0.0453094244874119
down	GBX2; PRRX1; FOXG1; DLX5; DLX6; SIX1; SIX4;	GO:0042472~inner ear morphogenesis	7	57	12.280701754386	0.00011440252053596	0.00545080342636965	0.256490451041625	0.261638564465743	0.228179447281712	0.256261646000553	0.0453094244874119
down	GLI2; TNC; MSX1; DLX1; DLX2; AMTN; EDAR;	GO:0042475~odontogenesis of dentin-containing tooth	7	57	12.280701754386	0.00011440252053596	0.00545080342636965	0.256490451041625	0.261638564465743	0.228179447281712	0.256261646000553	0.0453094244874119
down	NKX2-8; RBP4; GLI2; ITGA3; LOX; NKX2-1; TBX4; LHX3;	GO:0030324~lung development	8	80	10	0.00014081430494195	0.0065722921510661	0.315283228765025	0.322042315402239	0.260572254155874	0.315283228765025	0.0546317215343559
down	WT1; HOXA11; HOXD11; LHX1; SIX1; ADAMTS16;	GO:0001658~branching involved in ureteric bud morphogenesis	6	42	14.2857142857143	0.00016760867068876	0.00742566277922684	0.375108205001463	0.383321029865213	0.291303869657079	0.375108205001463	0.0617253055460942
down	HOXD9; HOXD10; HOXA10; HOXA11; FOXL2; DEFB126; FETUB;	GO:0007338~single fertilization	7	61	11.4754098360656	0.00016825510534634	0.00742566277922684	0.376386670659782	0.3847994259271	0.291926164832652	0.376386670659782	0.0617253055460942
down	GATA4; ISL1; TGFB2; SEMA3C;	GO:0003215~cardiac right ventricle morphogenesis	4	13	30.7692307692308	0.00017208575745475	0.00742566277922684	0.38478375366883	0.393560127299023	0.295987502822177	0.384611667911375	0.0617253055460942
down	PAX7; LHX1; LHX5; LHX3;	GO:0021527~spinal cord association neuron differentiation	4	13	30.7692307692308	0.00017208575745475	0.00742566277922684	0.38478375366883	0.393560127299023	0.295987502822177	0.384611667911375	0.0617253055460942
down	GLI2; MSX1; NKX2-1; ISL1; LHX3;	GO:0021983~pituitary gland development	5	27	18.5185185185185	0.00020256615736502	0.00842306912534204	0.452330229396101	0.463268801893812	0.32734691030188	0.452330229396101	0.0700161764485275
down	KITLG; GBX2; ISL1; ALX1; SEMA3A; SEMA3C;	GO:0001755~neural crest cell migration	6	44	13.6363636363636	0.00021081787184495	0.00860965130195397	0.470545489957949	0.482140472909422	0.33541123410533	0.470545489957949	0.0715671278185581
down	NKX2-1; DLX1; DLX2; CDK5R2; FEZ1; LHX5; HSD3B1;	GO:0021766~hippocampus development	7	64	10.9375	0.00022078499965427	0.00870578093464367	0.492350549229039	0.504935294209333	0.345090692471351	0.492350549229039	0.0723661987063992
down	FOXE1; GLI2; TGFB2; KRT27; FOXQ1;	GO:0031069~hair follicle morphogenesis	5	28	17.8571428571429	0.00023537661947459	0.00899141737510725	0.524654484808866	0.538306328738392	0.358713968079278	0.524654484808866	0.074740531757455
down	PITX3; IGF2; PAX3; LHX1; PDX1; LHX3; LAMC2; LAMB3; LAMA3;	GO:0009887~animal organ morphogenesis	9	111	8.10810810810811	0.00023982355045104	0.00899141737510725	0.53432687040493	0.548476459881542	0.36277560397237	0.534087046854479	0.074740531757455
down	NTRK1; MDK; ITGA3; CNTN1; PRKD1; NTRK2; PLPPR5; FEZ1; TENM3;	GO:0010976~positive regulation of neuron projection development	9	111	8.10810810810811	0.00023982355045104	0.00899141737510725	0.53432687040493	0.548476459881542	0.36277560397237	0.534087046854479	0.074740531757455
down	MMP1; ELANE; MMP3; MMP10; MMP13; CTRB2; KLK5;	GO:0022617~extracellular matrix disassembly	7	66	10.6060606060606	0.00026261238551894	0.00947076985876957	0.584312557779654	0.600594525681828	0.38182613675707	0.584312557779654	0.0787251159485266
down	SEMA3A; SIX1; SIX4;	GO:0061551~trigeminal ganglion development	3	5	60	0.0002650324752782	0.00947076985876957	0.589432225018726	0.606129270961253	0.383259637753539	0.589432225018726	0.0787251159485266
up	F2; JCHAIN; IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; IGKV1-16; IGKV3-11; ATP1B1; IGKV2-30; IGKV4-1; IGHV4-34; CEACAM5; CD48; IGLC2; IGLC3; PSG1; VPREB1; SELE; SDC1; IGHV1-2; CEACAM8; CEACAM3; IGLV3-21; ANGPT1; NKX2-3; FCAMR; FOXJ1; SIRPG; CD84;	GO:0050900~leukocyte migration	54	193	27.979274611399	0.00028406998366825	0.119082137153733	1	1	1	1	1
down	MSX1; MMP13; HAS2; PAPPA2; RARB;	GO:0060349~bone morphogenesis	5	30	16.6666666666667	0.00031295380117046	0.0110111591273363	0.69569630000195	0.71572534327686	0.413121590140295	0.69569630000195	0.0915294946402434
down	HOXB8; HOXD9; HOXD10; EN1; DMBX1; FOXA2;	GO:0008344~adult locomotory behavior	6	48	12.5	0.00032329507296469	0.0112026641192462	0.718361652127544	0.739375831870248	0.418831386138965	0.718361652127544	0.0931213665701548
down	GLI2; RARB; TGFB2; FOXF2;	GO:0048566~embryonic digestive tract development	4	16	25	0.00033624364050366	0.0113086647916453	0.746797125558638	0.768989205831879	0.425951501749307	0.746460881918134	0.0940024897892471
down	ISL1; SIX1; DMRTA2; ISL2;	GO:0048665~neuron fate specification	4	16	25	0.00033624364050366	0.0113086647916453	0.746797125558638	0.768989205831879	0.425951501749307	0.746460881918134	0.0940024897892471
down	HOXD9; HOXD10; CAV1; SIX1; SIX4; POPDC3;	GO:0007519~skeletal muscle tissue development	6	50	12	0.0003947987605628	0.0128986395058163	0.87566365092831	0.902904765407144	0.455992568450044	0.87566365092831	0.107219044049874
down	PRRX1; DLX2; SIX1; SIX2; SIX4;	GO:0048701~embryonic cranial skeleton morphogenesis	5	32	15.625	0.0004084819893978	0.0131577226725743	0.905604570494927	0.934198309752773	0.46281009398771	0.905604570494927	0.109372654859501
down	HOXD9; MSX1; HOXA11; EN1; ALX4;	GO:0035115~embryonic forelimb morphogenesis	5	33	15.1515151515152	0.00046376370011824	0.0145291449612388	1	1	0.488806939924632	0.99600186002898	0.120772507279052
down	BMPR1B; DLX1; DLX5; SFRP1; GATA5;	GO:0071773~cellular response to BMP stimulus	5	33	15.1515151515152	0.00046376370011824	0.0145291449612388	1	1	0.488806939924632	0.99600186002898	0.120772507279052
down	LHX2; DLX2; SEMA3A; NR2E1;	GO:0021772~olfactory bulb development	4	18	22.2222222222222	0.00049399282400752	0.0150634878467362	1	1	0.501663075397879	0.99600186002898	0.125214195361896
down	TGFB2; SIX1; SIX4;	GO:0048699~generation of neurons	3	7	42.8571428571429	0.00055350196916015	0.0164397273177827	1	1	0.526931786934226	0.99600186002898	0.136654090275059
down	DLX2; DLX5; DLX1; DLX6;	GO:0009790~embryo development	4	19	21.0526315789474	0.00058989301247702	0.0172959656350636	1	1	0.542111678466388	0.99600186002898	0.143771511753218
down	NTRK1; GLI2; RARB; MIF; DPEP1; WT1; AZU1; PAX7; MT3; MSX1; FLT4; HMGA2; ACTC1; SFRP1; IL31RA; BIRC7; FAIM2; LHX3; SIX4; NR2E1;	GO:0043066~negative regulation of apoptotic process	20	489	4.08997955010225	0.00062249462992025	0.0177298787396646	1	1	0.555752509373033	0.99600186002898	0.147378384265242
down	HOXC11; GLI2; HOXA11; HOXD12; HOXD13; ALX4;	GO:0042733~embryonic digit morphogenesis	6	55	10.9090909090909	0.00062794935632393	0.0177298787396646	1	1	0.557619028415651	0.99600186002898	0.147378384265242
up	COLEC12; IGHV3-11; IGHV4-39; IGHV3-74; IGHG2; IGHV3-30; IGHV1-2; TRDC; IGHV1-46; TRBC2; IGHA2; IGHV1-3; IGHV1-18; IGHG4; IGHV3-15; IGHV3-20; IGHV3-21; IGLC3; IGHV3-23; IGHG3; IGHV3-7; IGHV2-5; IGHD; TRBC1; IGHV5-51; IGHV3-73; IGLC2; IGKC; IGHV3-48; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	32	99	32.3232323232323	0.00066100678294667	0.245686471205646	1	1	1	1	1
down	FOXE1; ZIC2; WT1; MT3; NKX2-1; LHX1; HMGA2; FOXG1; FOXL2; FOXF2; FOXD1; IFNL1; SFRP1; ESX1; DMBX1; HMX1; SIX4; SIX2; ZNF488; SIX1; ALX1;	GO:0045892~negative regulation of transcription, DNA-templated	21	530	3.9622641509434	0.00068104620815345	0.0188810770606195	1	1	0.576956110886595	0.99600186002898	0.156947640265377
down	CLDN1; DLX1; CAV1; POSTN; SFRP1; PPARGC1A;	GO:0071560~cellular response to transforming growth factor beta stimulus	6	56	10.7142857142857	0.00068523366682615	0.0188810770606195	1	1	0.578508211273341	0.99600186002898	0.156947640265377
down	MSX1; PRRX1; SIX1; SIX2;	GO:0042474~middle ear morphogenesis	4	20	20	0.00069829103959384	0.0190118048517991	1	1	0.583283144310271	0.99600186002898	0.158034305940055
down	WT1; SIX1; SIX4;	GO:0072075~metanephric mesenchyme development	3	8	37.5	0.00075135063833353	0.0202157518808094	1	1	0.602583211943496	0.99600186002898	0.168042031908283
down	CLDN1; TGFB2; SDK1; MARVELD3;	GO:0045216~cell-cell junction organization	4	21	19.047619047619	0.00082005458332745	0.0217844956839412	1	1	0.620714803465352	0.99600186002898	0.181082105697082
down	KCNQ1; KCNJ2; CAV1; DSG2; PKP2;	GO:0086091~regulation of heart rate by cardiac conduction	5	38	13.1578947368421	0.00082870621972142	0.0217844956839412	1	1	0.622613169985159	0.99600186002898	0.181082105697082
down	REG1A; ALOX15; CDH3; TNC; LOX; EPPK1; TGFB2;	GO:0042060~wound healing	7	82	8.53658536585366	0.00087695794581743	0.0227909411600509	1	1	0.634040594826006	0.99600186002898	0.189448113739104
up	UGT1A9; UGT1A1; UGT1A3; UGT2B28; UGT1A7; UGT1A8; UGT1A10; UGT1A6;	GO:0052697~xenobiotic glucuronidation	8	9	88.8888888888889	0.00092635522141904	0.296513461528505	1	1	1	1	1
down	NKX2-8; EPPK1; ISL1; TGFB2; SFRP1; MARVELD3;	GO:0050680~negative regulation of epithelial cell proliferation	6	60	10	0.00095581637541286	0.0242883561174358	1	1	0.652822584406987	0.99600186002898	0.201895271457125
down	AZU1; P2RY1; TGFB2;	GO:0008347~glial cell migration	3	9	33.3333333333333	0.00098902464736394	0.0248560370167181	1	1	0.660668464439115	0.99600186002898	0.206614079461564
up	MS4A1; CD19; CTLA4; MNDA; NCKAP1L; IGHV4-34; IGHV3-33; IGHV3-11; IGHV3-21; IGHV4-39; IGHV1-2; IGHV2-5; IGLC3; IGHV3-30; TRBC2; IGHV5-51; CD79B; IGHG2; IGHV3-23; IGHV1-3; IGHV3-73; IGHG4; IGHV1-46; IGHV4-59; IGHG3; IGHV1-18; TRBC1; IGHA2; IGHV3-74; IGHV3-20; TRDC; IGHD; IGHV3-15; IGHV3-48; IGLC2; IGHV3-7; IGKC;	GO:0050853~B cell receptor signaling pathway	37	125	29.6	0.00103268858492345	0.296513461528505	1	1	1	1	1
up	IGHG3; IGHG4; IGLC3; IGHV3-15; IGHV4-39; IGHV3-21; IGHD; IGHV4-59; IGHV3-73; IGHV3-23; IGHV1-2; TRBC1; IGHV1-18; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGLC2; IGHV3-20; IGHV1-46; IGHV5-51; IGHV1-3; IGHV4-34; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV2-5;	GO:0050871~positive regulation of B cell activation	31	98	31.6326530612245	0.00106099759611822	0.296513461528505	1	1	1	1	1
down	DSCAM; LHX1; SDK1; FJX1;	GO:0010842~retina layer formation	4	23	17.3913043478261	0.00110716250629617	0.0275226157815145	1	1	0.686440753903623	0.99600186002898	0.22877983003675
up	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A6; UGT1A10;	GO:0052696~flavonoid glucuronidation	7	7	100	0.0012562368688469	0.329134059637889	1	1	1	1	1
down	HOXC11; HOXA11; SIX1;	GO:0001759~organ induction	3	10	30	0.00126934923882704	0.0312150721419081	1	1	0.719375374610337	0.99600186002898	0.259473116796083
down	NPR1; AZU1; HRH1;	GO:0043114~regulation of vascular permeability	3	11	27.2727272727273	0.00159496843682461	0.0372213552552844	1	1	0.773559691859934	0.99600186002898	0.309399927559243
down	INHBA; ITGA3; HMGA2;	GO:0048333~mesodermal cell differentiation	3	11	27.2727272727273	0.00159496843682461	0.0372213552552844	1	1	0.773559691859934	0.99600186002898	0.309399927559243
down	ELANE; TGFB2; IFNL1;	GO:0050778~positive regulation of immune response	3	11	27.2727272727273	0.00159496843682461	0.0372213552552844	1	1	0.773559691859934	0.99600186002898	0.309399927559243
down	INHBA; EPHA8; PPARGC1A;	GO:0071372~cellular response to follicle-stimulating hormone stimulus	3	11	27.2727272727273	0.00159496843682461	0.0372213552552844	1	1	0.773559691859934	0.99600186002898	0.309399927559243
down	CAV1; DSG2; PKP2;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	3	11	27.2727272727273	0.00159496843682461	0.0372213552552844	1	1	0.773559691859934	0.99600186002898	0.309399927559243
up	FCGR2B; AIF1; DOCK1; IGHG2; IGHV1-2; IGHV3-33; IGHV3-30; IGLC2; IGHV3-7; IGHA2; IGHV3-20; IGHV3-74; IGHV3-21; IGHV2-5; TRDC; TRBC2; IGHV3-11; IGHV4-39; IGHV1-3; IGHV1-46; IGHV4-59; IGHV3-73; IGHV3-15; IGHG3; IGHV3-48; IGKC; IGHV4-34; IGLC3; IGHV5-51; IGHG4; IGHV1-18; IGHD; TRBC1; IGHV3-23;	GO:0006911~phagocytosis, engulfment	34	115	29.5652173913043	0.0016334744690667	0.402795586725153	1	1	1	1	1
down	IGF2; IL5; MIF; LIF; IL11; KITLG; CNTN1;	GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation	7	92	7.60869565217391	0.00163566104949842	0.0372643602915275	1	1	0.779231575600283	0.99600186002898	0.309757403932874
down	KRT76; EN1; EDAR; TYRP1;	GO:0043473~pigmentation	4	26	15.3846153846154	0.00165983299082584	0.0372643602915275	1	1	0.782537689403119	0.99600186002898	0.309757403932874
down	CYP26A1; RBP4; TRIML2; RXRG; RARB;	GO:0032526~response to retinoic acid	5	46	10.8695652173913	0.00180673958326583	0.0386169479152238	1	1	0.800613004529627	0.99600186002898	0.321000694509451
down	SOX1; PITX3; SOX11;	GO:0002089~lens morphogenesis in camera-type eye	3	12	25	0.00196835166529552	0.0398916771231048	1	1	0.818096288018729	0.99600186002898	0.331596792418058
down	LHX1; FAIM2; LHX5;	GO:0021702~cerebellar Purkinje cell differentiation	3	12	25	0.00196835166529552	0.0398916771231048	1	1	0.818096288018729	0.99600186002898	0.331596792418058
down	EMX2; ARX; LHX5;	GO:0021846~cell proliferation in forebrain	3	12	25	0.00196835166529552	0.0398916771231048	1	1	0.818096288018729	0.99600186002898	0.331596792418058
down	LAMB3; LAMC2; LAMA3;	GO:0031581~hemidesmosome assembly	3	12	25	0.00196835166529552	0.0398916771231048	1	1	0.818096288018729	0.99600186002898	0.331596792418058
down	SOX11; HMGA2; NR2E1;	GO:2000648~positive regulation of stem cell proliferation	3	12	25	0.00196835166529552	0.0398916771231048	1	1	0.818096288018729	0.99600186002898	0.331596792418058
down	DLX1; HTRA3; RBPMS2; SFRP1; SOST;	GO:0030514~negative regulation of BMP signaling pathway	5	47	10.6382978723404	0.00197103607997851	0.0398916771231048	1	1	0.818096288018729	0.99600186002898	0.331596792418058
down	RARB; ISL1; TGFB2; SEMA3C;	GO:0003148~outflow tract septum morphogenesis	4	28	14.2857142857143	0.00211969234186304	0.0417908309124205	1	1	0.83422633577734	0.99600186002898	0.347383376243608
down	INHBA; HMGA2; LAMB3; LAMA3;	GO:0035987~endodermal cell differentiation	4	28	14.2857142857143	0.00211969234186304	0.0417908309124205	1	1	0.83422633577734	0.99600186002898	0.347383376243608
down	GABRD; SLC26A4; GABRA1; CLDN17; ANO4; ANO1; SLC26A10;	GO:1902476~chloride transmembrane transport	7	97	7.21649484536082	0.0021689577516758	0.0423966357101074	1	1	0.839386649898536	0.99600186002898	0.352419086502781
down	PITX3; EN2; MSX1; EN1;	GO:0030901~midbrain development	4	29	13.7931034482759	0.0023795979587744	0.0448364507552872	1	1	0.861660591366781	0.99600186002898	0.372699879425533
down	MDK; CDH3; HAS2;	GO:0010838~positive regulation of keratinocyte proliferation	3	13	23.0769230769231	0.00239180017146701	0.0448364507552872	1	1	0.863439861899589	0.99600186002898	0.372699879425533
down	BMPR1B; TBX4; EVX2;	GO:0035108~limb morphogenesis	3	13	23.0769230769231	0.00239180017146701	0.0448364507552872	1	1	0.863439861899589	0.99600186002898	0.372699879425533
down	GATA4; ISL1; TGFB2;	GO:0060413~atrial septum morphogenesis	3	13	23.0769230769231	0.00239180017146701	0.0448364507552872	1	1	0.863439861899589	0.99600186002898	0.372699879425533
down	MSX1; SOX11; LHX2;	GO:2000678~negative regulation of transcription regulatory region DNA binding	3	13	23.0769230769231	0.00239180017146701	0.0448364507552872	1	1	0.863439861899589	0.99600186002898	0.372699879425533
down	NR2E1; SIX1; SIX4; SIX2; RXRG;	GO:0048856~anatomical structure development	5	50	10	0.00252939951682118	0.0458335682316554	1	1	0.877701632336951	0.99600186002898	0.380988349118279
down	CACNG3; GNGT1; CAV1; MGAT3; TNS4; CCDC68;	GO:0008104~protein localization	6	74	8.10810810810811	0.00258323815565065	0.0458335682316554	1	1	0.883467449232521	0.99600186002898	0.380988349118279
down	LHX2; TCF15; FOXC2; HES7;	GO:0007498~mesoderm development	4	30	13.3333333333333	0.00266060111676703	0.0458335682316554	1	1	0.891054471019294	0.99600186002898	0.380988349118279
down	LHX1; LHX3; LAMC2; SEMA3A;	GO:0008045~motor neuron axon guidance	4	30	13.3333333333333	0.00266060111676703	0.0458335682316554	1	1	0.891054471019294	0.99600186002898	0.380988349118279
down	ADRA2C; HRH1; CAV1; ADRA1B;	GO:0045907~positive regulation of vasoconstriction	4	30	13.3333333333333	0.00266060111676703	0.0458335682316554	1	1	0.891054471019294	0.99600186002898	0.380988349118279
down	LIF; MSX1; HMGA2; PDX1;	GO:0048863~stem cell differentiation	4	30	13.3333333333333	0.00266060111676703	0.0458335682316554	1	1	0.891054471019294	0.99600186002898	0.380988349118279
down	CLDN3; FGF19; IGF2; NTRK1; MT3; FLT4; P2RY1; NTRK2; KNDC1;	GO:0001934~positive regulation of protein phosphorylation	9	161	5.59006211180124	0.00284280121645175	0.0458335682316554	1	1	0.903124531582902	0.99600186002898	0.380988349118279
down	GATA4; NTRK2; NTRK1;	GO:0051896~regulation of protein kinase B signaling	3	14	21.4285714285714	0.00286745326017068	0.0458592000420304	1	1	0.904652892665372	0.99600186002898	0.381201411759842
down	GLI2; HOXD12; LHX1; SIX1;	GO:0007389~pattern specification process	4	31	12.9032258064516	0.00296352335101668	0.0470665132206608	1	1	0.910740901240922	0.99600186002898	0.391237118612739
up	CCR2; CXCR3; CCR5; CCR6; CCR8; CX3CL1; GPR17; ACKR1; CCL23; CCL2; CCL16; CCL21; CCL11; CCL13; CCL1; CCL14; TFF2; XCL2; CXCL13; CCL8; CCL17; CCL18; CCL19;	GO:0070098~chemokine-mediated signaling pathway	23	70	32.8571428571429	0.00298460032616232	0.658497082488024	1	1	1	1	1
down	OOEP; MPPED1; PRB2; CRYBA2; DIO3; EVX2; WT1-AS; ACTBL2; C5orf46; C6orf15; IGFL3; PTCHD4; KNDC1; ASCL5; KRT27; MAGEB6; POPDC3; KRT82; SPANXC; FETUB; INSL5;	GO:0008150~biological_process	21	603	3.48258706467662	0.00305596822087895	0.0481999953182769	1	1	0.915050655474921	0.99600186002898	0.400659109738178
down	ALOX15; CYGB; PPARGC1A;	GO:0019395~fatty acid oxidation	3	15	20	0.00339729434345526	0.0524973794829877	1	1	0.930858650106741	0.99600186002898	0.436380816810276
down	LIF; TGFB2; FOXC2;	GO:0033630~positive regulation of cell adhesion mediated by integrin	3	15	20	0.00339729434345526	0.0524973794829877	1	1	0.930858650106741	0.99600186002898	0.436380816810276
down	NTRK1; SOX11; SEMA3A;	GO:0048485~sympathetic nervous system development	3	15	20	0.00339729434345526	0.0524973794829877	1	1	0.930858650106741	0.99600186002898	0.436380816810276
down	CCL24; VGF; PLAU; GAST; REG1A; CGB7; RARB; MDK; GRIA2; GNG10; MAPK10; GNGT1; TNFAIP6; IL1RL1; INSL4; PRKD1; ARTN; CD200R1; CASKIN1; DPYSL5; RETNLB; FGF21; TENM2; TENM3; CCL26; GABRD; PLPPR5; NPR1; SCUBE2; GABRA1;	GO:0007165~signal transduction	30	989	3.03336703741153	0.00347904660039633	0.0533998629201772	1	1	0.934555322660381	0.99600186002898	0.443882647632253
down	VGF; GAL; PDX1; MAFA;	GO:0030073~insulin secretion	4	33	12.1212121212121	0.00363834868338753	0.0551053207874654	1	1	0.94205825385091	0.99600186002898	0.458059147573624
down	HOXD8; HOXC8; TBX4; TCF15;	GO:0048705~skeletal system morphogenesis	4	33	12.1212121212121	0.00363834868338753	0.0551053207874654	1	1	0.94205825385091	0.99600186002898	0.458059147573624
down	GLI2; RARB; ADRA2C; SOX11; FOXG1; GDF6;	GO:0045666~positive regulation of neuron differentiation	6	81	7.40740740740741	0.00392575352766011	0.0564414438798945	1	1	0.951514387346278	0.99600186002898	0.469165577878822
down	ST8SIA3; ST8SIA6; ST6GALNAC5;	GO:0009311~oligosaccharide metabolic process	3	16	18.75	0.00398315681052441	0.0564414438798945	1	1	0.953003455245098	0.99600186002898	0.469165577878822
down	MDK; EMX2; NR2E1;	GO:0021542~dentate gyrus development	3	16	18.75	0.00398315681052441	0.0564414438798945	1	1	0.953003455245098	0.99600186002898	0.469165577878822
down	SYT1; SYT3; RIMS4;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	3	16	18.75	0.00398315681052441	0.0564414438798945	1	1	0.953003455245098	0.99600186002898	0.469165577878822
down	DSCAM; VSTM2L; MYPN;	GO:0070593~dendrite self-avoidance	3	16	18.75	0.00398315681052441	0.0564414438798945	1	1	0.953003455245098	0.99600186002898	0.469165577878822
down	MMP3; DPEP1; MT3;	GO:0071732~cellular response to nitric oxide	3	16	18.75	0.00398315681052441	0.0564414438798945	1	1	0.953003455245098	0.99600186002898	0.469165577878822
down	SOX1; ITGA3; NKX2-1; CDK5R2; SEMA3A; NTRK2; VAX1;	GO:0001764~neuron migration	7	109	6.42201834862385	0.00399405412843379	0.0564414438798945	1	1	0.953509176418283	0.99600186002898	0.469165577878822
down	PRODH; KCNK2; MT3; PDX1;	GO:0010942~positive regulation of cell death	4	34	11.7647058823529	0.00401182926974375	0.0564414438798945	1	1	0.95401969115709	0.99600186002898	0.469165577878822
down	MSX1; SOX11; GATA4; FOXD1;	GO:0030513~positive regulation of BMP signaling pathway	4	34	11.7647058823529	0.00401182926974375	0.0564414438798945	1	1	0.95401969115709	0.99600186002898	0.469165577878822
down	CHP2; ALOX15; DPEP1; SYT1; LCE1D; SYT3;	GO:0071277~cellular response to calcium ion	6	82	7.31707317073171	0.00415300587622602	0.0564414438798945	1	1	0.957733435629587	0.99600186002898	0.469165577878822
down	FOSL1; FOXG1; TGFB2; NR2E1;	GO:0045787~positive regulation of cell cycle	4	35	11.4285714285714	0.0044103820297331	0.0586426959418581	1	1	0.96472986494831	0.99600186002898	0.487463332590869
down	CPA1; ALOX15; DPEP1;	GO:0006691~leukotriene metabolic process	3	17	17.6470588235294	0.00462672972285916	0.0608122464148212	1	1	0.970579338641012	0.99600186002898	0.505497570048561
down	PLAU; P2RY1; PCSK9;	GO:0010469~regulation of signaling receptor activity	3	17	17.6470588235294	0.00462672972285916	0.0608122464148212	1	1	0.970579338641012	0.99600186002898	0.505497570048561
down	BMPR1B; DLX1; ISL1; DLX2;	GO:0045597~positive regulation of cell differentiation	4	36	11.1111111111111	0.00483475727356242	0.0631833707693557	1	1	0.974282110294131	0.99600186002898	0.525207376381386
down	DPEP1; MT3; CERS1; KCNQ1; FGF21;	GO:0035690~cellular response to drug	5	59	8.47457627118644	0.00488715282175445	0.0635052187690479	1	1	0.97523614565401	0.99600186002898	0.52788271550074
down	PACSIN1; SYT1; ACTL8; ACTBL2;	GO:0048488~synaptic vesicle endocytosis	4	37	10.8108108108108	0.00528568848877642	0.0662429965006889	1	1	0.982550416746415	0.99600186002898	0.550640302537359
down	GLI2; EN2; GBX2;	GO:0030902~hindbrain development	3	18	16.6666666666667	0.00532956333892731	0.0662429965006889	1	1	0.98311979114283	0.99600186002898	0.550640302537359
down	BMPR1B; ISL1; ISL2;	GO:0031290~retinal ganglion cell axon guidance	3	18	16.6666666666667	0.00532956333892731	0.0662429965006889	1	1	0.98311979114283	0.99600186002898	0.550640302537359
down	SOX11; RBPMS2; SIX2;	GO:0048557~embryonic digestive tract morphogenesis	3	18	16.6666666666667	0.00532956333892731	0.0662429965006889	1	1	0.98311979114283	0.99600186002898	0.550640302537359
down	RBP4; GATA4; GATA5;	GO:0048738~cardiac muscle tissue development	3	18	16.6666666666667	0.00532956333892731	0.0662429965006889	1	1	0.98311979114283	0.99600186002898	0.550640302537359
down	SYT1; GRIK2; RIMS4;	GO:0050806~positive regulation of synaptic transmission	3	18	16.6666666666667	0.00532956333892731	0.0662429965006889	1	1	0.98311979114283	0.99600186002898	0.550640302537359
down	ISL1; SIX1; SIX4;	GO:0060037~pharyngeal system development	3	18	16.6666666666667	0.00532956333892731	0.0662429965006889	1	1	0.98311979114283	0.99600186002898	0.550640302537359
down	LHX1; SIX1; SIX4;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	3	18	16.6666666666667	0.00532956333892731	0.0662429965006889	1	1	0.98311979114283	0.99600186002898	0.550640302537359
down	CLDN3; KRT16; MIF; DPEP1; NKX2-1; EPPK1; SFRP1;	GO:0030336~negative regulation of cell migration	7	116	6.03448275862069	0.00549335808019424	0.0678100757358011	1	1	0.986072102827944	0.99600186002898	0.563666539720232
down	MIF; LIF; IL11; CAV1; PRKD1; NTRK2;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	6	88	6.81818181818182	0.0057257636543675	0.0678100757358011	1	1	0.990525331679425	0.99600186002898	0.563666539720232
down	VGF; INHBA; KITLG; FOXL2;	GO:0001541~ovarian follicle development	4	38	10.5263157894737	0.00576389163459323	0.0678100757358011	1	1	0.991194555310167	0.99600186002898	0.563666539720232
down	INHBA; MDK; TNC; PDX1; TGFB2;	GO:0009611~response to wounding	5	62	8.06451612903226	0.00593634096372553	0.0685677362830317	1	1	0.993960679650567	0.99600186002898	0.569964540338959
down	MDK; SFRP1; SOST;	GO:0030279~negative regulation of ossification	3	19	15.7894736842105	0.00609307447286045	0.0693276682558798	1	1	0.99600186002898	0.99600186002898	0.5762814220252
down	BMPR1B; HOXA11; GDF6;	GO:0032332~positive regulation of chondrocyte differentiation	3	19	15.7894736842105	0.00609307447286045	0.0693276682558798	1	1	0.99600186002898	0.99600186002898	0.5762814220252
down	NPR1; P2RY1; FOXC2;	GO:0097746~regulation of blood vessel diameter	3	19	15.7894736842105	0.00609307447286045	0.0693276682558798	1	1	0.99600186002898	0.99600186002898	0.5762814220252
down	WT1; LAMB3; LAMC2; LAMA3;	GO:0009888~tissue development	4	39	10.2564102564103	0.00627006449764855	0.0709883044857537	1	1	0.99600186002898	0.99600186002898	0.590085345222012
down	HOXC11; GATA4; NKX2-1;	GO:0007492~endoderm development	3	20	15	0.00691855169189415	0.077184037655424	1	1	0.99600186002898	0.99600186002898	0.641586946405656
down	FGF5; MSX1; P2RY1;	GO:0023019~signal transduction involved in regulation of gene expression	3	20	15	0.00691855169189415	0.077184037655424	1	1	0.99600186002898	0.99600186002898	0.641586946405656
down	GLI2; RARB; PTHLH;	GO:0032331~negative regulation of chondrocyte differentiation	3	20	15	0.00691855169189415	0.077184037655424	1	1	0.99600186002898	0.99600186002898	0.641586946405656
down	NKX2-1; MAPK10; HLF; SPSB4; HES7;	GO:0048511~rhythmic process	5	66	7.57575757575758	0.00756894955627485	0.0772942672525995	1	1	0.99600186002898	0.99600186002898	0.642503222267915
down	INHBA; NPR1; WT1; MT3; MSX1; TGFB2; SFRP1;	GO:0030308~negative regulation of cell growth	7	124	5.64516129032258	0.00768295387322671	0.0772942672525995	1	1	0.99600186002898	0.99600186002898	0.642503222267915
down	SOX11; CYP26C1; FOXC2;	GO:0014032~neural crest cell development	3	21	14.2857142857143	0.0078071603565153	0.0772942672525995	1	1	0.99600186002898	0.99600186002898	0.642503222267915
down	CLDN3; CLDN1; CLDN17;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	3	21	14.2857142857143	0.0078071603565153	0.0772942672525995	1	1	0.99600186002898	0.99600186002898	0.642503222267915
down	ITGA3; LOX; SOX11;	GO:0017015~regulation of transforming growth factor beta receptor signaling pathway	3	21	14.2857142857143	0.0078071603565153	0.0772942672525995	1	1	0.99600186002898	0.99600186002898	0.642503222267915
down	CACNG3; CACNG4; SHISA9;	GO:2000311~regulation of AMPA receptor activity	3	21	14.2857142857143	0.0078071603565153	0.0772942672525995	1	1	0.99600186002898	0.99600186002898	0.642503222267915
up	TNFRSF13B; CXCL13; LILRA1; TRPA1; ADGRL2; TSPAN12; F2; IFNG; IL2RA; CD3D; CD3G; CCL2; EDN3; EDN2; EDNRB; LAMA1; KLRC1; CCKBR; ADCYAP1R1; GLP1R; GCGR; SCTR; CXCR3; CCR5; ADGRE1; ADGRF5; LILRB2; CLEC1A; MAGI1; ADGRE3; ADGRL3; CBLC; CLEC4A; TRBV24-1; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV27; TRBV3-1; TRBV2; TRBV28; TRBV6-2; TRBV7-2; TRBV4-1; TRBV29-1; TRBV30; TRBV4-2; TRBV20-1; TRBV6-5; TRBV12-4; TRBV5-6; TRBV23-1; TRBV5-4; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	61	268	22.7611940298507	0.00785104291181182	1	1	1	1	1	1
down	MDK; ISL1; TGFB2; ALX1;	GO:0010718~positive regulation of epithelial to mesenchymal transition	4	42	9.52380952380952	0.00796309474011858	0.0778179163759967	1	1	0.99600186002898	0.99600186002898	0.646856019196839
down	FOSL1; TGFB2; CAV1; DSG2;	GO:0032570~response to progesterone	4	42	9.52380952380952	0.00796309474011858	0.0778179163759967	1	1	0.99600186002898	0.99600186002898	0.646856019196839
down	WT1; VAX1; PITX2; FOXC2;	GO:0043010~camera-type eye development	4	42	9.52380952380952	0.00796309474011858	0.0778179163759967	1	1	0.99600186002898	0.99600186002898	0.646856019196839
down	CLDN1; POSTN; SFRP1; HAS2; PPARGC1A; CCL26; CCL24;	GO:0071356~cellular response to tumor necrosis factor	7	125	5.6	0.00799615668926945	0.0778179163759967	1	1	0.99600186002898	0.99600186002898	0.646856019196839
down	WT1; DLX5; DLX6; SIX1; ACTL8;	GO:0030855~epithelial cell differentiation	5	68	7.35294117647059	0.00849210853300986	0.0822942890465828	1	1	0.99600186002898	0.99600186002898	0.684065555778956
down	MMP1; MMP3; MMP10; MMP13;	GO:0030574~collagen catabolic process	4	43	9.30232558139535	0.00858774150952557	0.0828698938071096	1	1	0.99600186002898	0.99600186002898	0.688850230329045
down	FOXE1; NKX2-1; SIX1;	GO:0030878~thyroid gland development	3	22	13.6363636363636	0.00875994750739717	0.0831286304955076	1	1	0.99600186002898	0.99600186002898	0.691000961061394
down	GLI2; HOXD9; CAV1;	GO:0030879~mammary gland development	3	22	13.6363636363636	0.00875994750739717	0.0831286304955076	1	1	0.99600186002898	0.99600186002898	0.691000961061394
down	CACNB4; CAV1; CACNG4;	GO:0051899~membrane depolarization	3	22	13.6363636363636	0.00875994750739717	0.0831286304955076	1	1	0.99600186002898	0.99600186002898	0.691000961061394
down	MDK; LHX2; NR2E1;	GO:2000179~positive regulation of neural precursor cell proliferation	3	22	13.6363636363636	0.00875994750739717	0.0831286304955076	1	1	0.99600186002898	0.99600186002898	0.691000961061394
down	LIF; ISL1; IFNL1; IL31RA; IL20;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	5	69	7.2463768115942	0.00898166565030967	0.0848804518275133	1	1	0.99600186002898	0.99600186002898	0.705562854079579
down	PTHLH; ALOX15; LOX; MMP13;	GO:0030282~bone mineralization	4	44	9.09090909090909	0.0092435557036884	0.0851386019552229	1	1	0.99600186002898	0.99600186002898	0.70770870906699
down	CYP7B1; CYP26A1; CYP26C1;	GO:0016125~sterol metabolic process	3	23	13.0434782608696	0.00977784660361392	0.0851386019552229	1	1	0.99600186002898	0.99600186002898	0.70770870906699
down	GLI2; HOXA11; DMBX1;	GO:0048589~developmental growth	3	23	13.0434782608696	0.00977784660361392	0.0851386019552229	1	1	0.99600186002898	0.99600186002898	0.70770870906699
down	REG1A; SYT1; SYT3;	GO:1903861~positive regulation of dendrite extension	3	23	13.0434782608696	0.00977784660361392	0.0851386019552229	1	1	0.99600186002898	0.99600186002898	0.70770870906699
down	CLDN3; PLAU; REG1A; MT3; TGFB2; CAV1; POSTN; CYGB;	GO:0001666~response to hypoxia	8	163	4.9079754601227	0.00979075308886035	0.0851386019552229	1	1	0.99600186002898	0.99600186002898	0.70770870906699
down	LOX; TGFB2; FOXC2; LOXL4;	GO:0030199~collagen fibril organization	4	45	8.88888888888889	0.00993111561234516	0.0857074015299373	1	1	0.99600186002898	0.99600186002898	0.712436815983178
down	SOX11; HLF; VAX1; DMRTA2;	GO:0035914~skeletal muscle cell differentiation	4	45	8.88888888888889	0.00993111561234516	0.0857074015299373	1	1	0.99600186002898	0.99600186002898	0.712436815983178
up	TGM5; PPL; KRT33A; KRT37; KRT38; IVL; KRT19; KRT3; KRT13; KRT4; FLG; SPRR1B; SPRR2D; TGM1; SPRR1A; SPRR2A; KRT6C; TCHH; KRT32; KRT31; PRSS8; KRT24; SPINK9; KRT40; KRT78; KRT35; SPRR2F; SPRR3; KLK12; KLK13;	GO:0070268~cornification	30	113	26.5486725663717	0.010362549218033	1	1	1	1	1	1
down	TCF15; FOXC2; SEMA3C; HES7;	GO:0001756~somitogenesis	4	46	8.69565217391304	0.0106509783279711	0.0912314136182396	1	1	0.99600186002898	0.99600186002898	0.758354782382707
down	KCNQ1; TGFB2; SIX1; LHX3;	GO:0048839~inner ear development	4	46	8.69565217391304	0.0106509783279711	0.0912314136182396	1	1	0.99600186002898	0.99600186002898	0.758354782382707
up	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.010715653213935	1	1	1	1	1	1
up	APOA1; APOE; APOC3; APOA4; LPL; GPIHBP1;	GO:0034371~chylomicron remodeling	6	9	66.6666666666667	0.0107452245155407	1	1	1	1	1	1
down	NKX2-1; SFRP1; FOXA2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	3	24	12.5	0.0108616821157073	0.0926890559650093	1	1	0.99600186002898	0.99600186002898	0.770471333040379
down	NTRK2; FLT4; ROS1; EPHA8; NTRK1;	GO:0033674~positive regulation of kinase activity	5	73	6.84931506849315	0.0111345050805252	0.0946639892905615	1	1	0.99600186002898	0.99600186002898	0.786887828991944
down	IGF2; FGF5; MDK; TGFB2;	GO:0051781~positive regulation of cell division	4	47	8.51063829787234	0.011403679497814	0.0965933889314834	1	1	0.99600186002898	0.99600186002898	0.802925829355978
down	CLDN3; STC2; FGF19; ROS1; MIF; SOX11; TGFB2; SFRP1; GATA5;	GO:0010629~negative regulation of gene expression	9	204	4.41176470588235	0.0118997774086921	0.0970659724695963	1	1	0.99600186002898	0.99600186002898	0.806854147157814
down	ISL1; FOXC2; PKP2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	3	25	12	0.0120121739778097	0.0970659724695963	1	1	0.99600186002898	0.99600186002898	0.806854147157814
down	CLDN1; KRT16; FLG2;	GO:0061436~establishment of skin barrier	3	25	12	0.0120121739778097	0.0970659724695963	1	1	0.99600186002898	0.99600186002898	0.806854147157814
down	INHBA; GDF6; TGFB2; INHBE;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	4	48	8.33333333333333	0.0121897331159682	0.0974752434832839	1	1	0.99600186002898	0.99600186002898	0.810256184002485
up	CCL11; CCL13; CCL1; CX3CL1; CCL18; CCL23; XCL2; CCL8; CCL2;	GO:0048245~eosinophil chemotaxis	9	20	45	0.0125435722224861	1	1	1	1	1	1
down	CCL24; KRT16; MDK; CTNNA2; KRT76; KRT84; PACSIN1;	GO:0007010~cytoskeleton organization	7	139	5.03597122302158	0.013429056995289	0.107011335708104	1	1	0.99600186002898	0.99600186002898	0.889524287576943
down	HRH1; JPH3; RIMS4; VGF;	GO:0048167~regulation of synaptic plasticity	4	50	8	0.0138638444288275	0.110092403502529	1	1	0.99600186002898	0.99600186002898	0.915135449391504
down	NKX2-8; CTNNA2; VAX2; ISL2; ISL1;	GO:0007409~axonogenesis	5	78	6.41025641025641	0.0142881115648796	0.11143153550819	1	1	0.99600186002898	0.99600186002898	0.926266891078727
down	LHX1; POSTN; SFRP1;	GO:0044344~cellular response to fibroblast growth factor stimulus	3	27	11.1111111111111	0.0145155095584939	0.11143153550819	1	1	0.99600186002898	0.99600186002898	0.926266891078727
down	SLC26A4; SIX1; ATCAY; SIX4;	GO:0032880~regulation of protein localization	4	51	7.84313725490196	0.0147528205003342	0.111720862530677	1	1	0.99600186002898	0.99600186002898	0.928671901836245
down	EN1; GAD1; NRXN1; NR2E1;	GO:0035176~social behavior	4	51	7.84313725490196	0.0147528205003342	0.111720862530677	1	1	0.99600186002898	0.99600186002898	0.928671901836245
down	PITX3; TGFB2; GRIK2; PCSK9;	GO:0043525~positive regulation of neuron apoptotic process	4	52	7.69230769230769	0.0156769856080279	0.118327610843432	1	1	0.99600186002898	0.99600186002898	0.983590037818902
down	STC2; KCNK2; MT3; GNGT1; SFRP1; PPARGC1A;	GO:0071456~cellular response to hypoxia	6	111	5.40540540540541	0.0158509525916645	0.118604930830536	1	1	0.99600186002898	0.99600186002898	0.985895240929653
down	FLT4; GATA4; ISL1;	GO:0010575~positive regulation of vascular endothelial growth factor production	3	28	10.7142857142857	0.0158693086288343	0.118604930830536	1	1	0.99600186002898	0.99600186002898	0.985895240929653
down	RARB; MSX1; ALX4;	GO:0035116~embryonic hindlimb morphogenesis	3	28	10.7142857142857	0.0158693086288343	0.118604930830536	1	1	0.99600186002898	0.99600186002898	0.985895240929653
down	TFPI; SFRP1; HAS2; CCL26; CCL24;	GO:0071347~cellular response to interleukin-1	5	81	6.17283950617284	0.0164417525700011	0.122483023216914	1	1	0.99600186002898	0.99600186002898	1
up	DEFB4A; CXCL13; HP; S100A8; S100A9; PRG2; IL10; RAG2; DEFB1; IRF8; COLEC12; GBP6; DEFB108B; S100A14; STAB1; SLAMF8; ADAMTS5; IGHV3-48; IGHG2; IGLC3; IGHG3; IGHV1-46; TRBC1; IGHV3-73; IGHV1-2; TRBC2; IGHV3-30; IGHA2; IGLC2; IGHV2-5; IGHD; IGHV3-74; IGHV1-18; IGHV3-7; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-23; HAMP; TRDC; IGHV3-20; IGKC; IGHV4-39; IGHV3-21; IGHV3-11; IGHV4-59; IGHV1-3; IGHV3-33; IGHG4;	GO:0042742~defense response to bacterium	49	216	22.6851851851852	0.0164693640334831	1	1	1	1	1	1
down	ZIC2; SYT1; MT3; NKX2-1; FOXG1; DLX2; VAX1; DMBX1; EMX2;	GO:0007420~brain development	9	217	4.14746543778802	0.016894630652054	0.123946790341441	1	1	0.99600186002898	0.99600186002898	1
down	HOXC11; HOXA11; FOXC2;	GO:0001656~metanephros development	3	29	10.3448275862069	0.0172916827275154	0.123946790341441	1	1	0.99600186002898	0.99600186002898	1
down	SCIN; SYT1; SYT3;	GO:0017156~calcium-ion regulated exocytosis	3	29	10.3448275862069	0.0172916827275154	0.123946790341441	1	1	0.99600186002898	0.99600186002898	1
up	PTH; ADRA2A; NOS1; STC1; CAV3; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	7	14	50	0.0178694081349839	1	1	1	1	1	1
down	GUCA2B; CTRB2; PPARGC1A;	GO:0007586~digestion	3	30	10	0.0187828912044182	0.133820785621509	1	1	0.99600186002898	0.99600186002898	1
down	BMPR1B; DLX5; GDF6; DSG4; TGFB2;	GO:0030509~BMP signaling pathway	5	85	5.88235294117647	0.0196339836537484	0.139450064025225	1	1	0.99600186002898	0.99600186002898	1
down	BMPR1B; LHX2; VAX2; NR2E1;	GO:0060041~retina development in camera-type eye	4	56	7.14285714285714	0.0197332817407583	0.139598204929518	1	1	0.99600186002898	0.99600186002898	1
down	RBP4; PAX7; DLX1;	GO:0048706~embryonic skeletal system development	3	31	9.67741935483871	0.0203431128258167	0.139713810908837	1	1	0.99600186002898	0.99600186002898	1
down	NKX2-1; PLA2G4E; PCSK9; PLPPR5;	GO:0006644~phospholipid metabolic process	4	57	7.01754385964912	0.0208390074673368	0.141962947297289	1	1	0.99600186002898	0.99600186002898	1
down	CYP7B1; DLX5; DLX6; SFRP1;	GO:0050679~positive regulation of epithelial cell proliferation	4	57	7.01754385964912	0.0208390074673368	0.141962947297289	1	1	0.99600186002898	0.99600186002898	1
up	S100A8; S100A9; SELE; CCR6; CX3CL1; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	6	11	54.5454545454545	0.0208741176615629	1	1	1	1	1	1
down	MDK; GRIK2; NR2E1;	GO:0001662~behavioral fear response	3	32	9.375	0.0219724493390594	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	LIF; FOXC2; SEMA3C;	GO:0001974~blood vessel remodeling	3	32	9.375	0.0219724493390594	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	IL31RA; FLT4; NTRK1; EPHA8; NTRK2; ROS1;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	6	120	5	0.0219772858241739	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	FOXG1; ISL1; ISL2; NR2E1;	GO:0045665~negative regulation of neuron differentiation	4	59	6.77966101694915	0.0231625727281827	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	TGFB2; GDF6; INHBE; INHBA;	GO:0060395~SMAD protein signal transduction	4	59	6.77966101694915	0.0231625727281827	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	INHBA; TGFB2; PITX2;	GO:0042476~odontogenesis	3	33	9.09090909090909	0.0236709289239001	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	WT1; CAV1; NTRK2; HAS2;	GO:0001570~vasculogenesis	4	60	6.66666666666667	0.0243809340551595	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	HRH1; P2RY1; ANO1; ADRA1B;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	4	60	6.66666666666667	0.0243809340551595	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
up	FZD7; WNT5A; MYOC; FZD10;	GO:0038031~non-canonical Wnt signaling pathway via JNK cascade	4	5	80	0.0247521267845823	1	1	1	1	1	1
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.0247521267845823	1	1	1	1	1	1
down	MSX1; SIX1; SIX4;	GO:0034504~protein localization to nucleus	3	34	8.82352941176471	0.0254385095332839	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	KCNQ2; KCNK2; KCNQ1; KCNJ2; SLC9A3; KCNF1;	GO:0071805~potassium ion transmembrane transport	6	125	4.8	0.0259888107635801	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	FOSL1; NTRK2; JPH3; NRXN1;	GO:0007612~learning	4	62	6.45161290322581	0.0269319570569011	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	BMPR1B; RBP4; TGFB2;	GO:0001654~eye development	3	35	8.57142857142857	0.0272750821273865	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	GABRD; GRIA2; GABRA1;	GO:0060078~regulation of postsynaptic membrane potential	3	35	8.57142857142857	0.0272750821273865	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
up	IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; IGLC2; IGLC3; FCER1A; IGHV1-2; LILRA4; IGLV3-21; MS4A2;	GO:0038095~Fc-epsilon receptor signaling pathway	39	171	22.8070175438596	0.0277589036134117	1	1	1	1	1	1
down	NUAK1; PLAU; MELTF; HOXD13; BIRC7; ARX; TGFB2;	GO:0042127~regulation of cell population proliferation	7	163	4.29447852760736	0.0281655288306129	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	ELANE; CAV1; GRIK2; STC2; ATP13A5;	GO:0006874~cellular calcium ion homeostasis	5	94	5.31914893617021	0.0282311048271816	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.0294997581524865	1	1	1	1	1	1
down	PITX3; CLDN1; NTRK1; KRT16; P2RY1; FOXG1; PPARGC1A;	GO:0007568~aging	7	166	4.21686746987952	0.0305623478802489	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	GLI2; HMGA2; SIX2;	GO:0002062~chondrocyte differentiation	3	37	8.10810810810811	0.0311544508179387	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	CCL24; GATA4; HMGA2; ISL1; PRKD1; NR2E1;	GO:0045766~positive regulation of angiogenesis	6	131	4.58015267175572	0.03140962459123	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
down	KRT75; INHBA; SFRP1; ANLN;	GO:0002244~hematopoietic progenitor cell differentiation	4	66	6.06060606060606	0.0324962715771959	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
up	APOE; APOA4; LPL; CETP; APOA1;	GO:0034372~very-low-density lipoprotein particle remodeling	5	9	55.5555555555556	0.0326633365304387	1	1	1	1	1	1
down	CLDN3; CLDN1; MARVELD3;	GO:0070830~bicellular tight junction assembly	3	38	7.89473684210526	0.0331967215281028	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
up	S100A8; S100A9; EDN3; EDN2; NCKAP1L; CCL1; XCL2; CCL8; CX3CL1; CCL21; CCL13; CCL16; CCL14; CCL17; CCL11; CCL18; CCL19; CXCL13; CCL23; CCL2;	GO:0030593~neutrophil chemotaxis	20	76	26.3157894736842	0.0340477015667564	1	1	1	1	1	1
down	GRIA2; GRIK2; ANO4; ATP13A5; ANO1; TMC7; GABRA1; GABRD;	GO:0034220~ion transmembrane transport	8	208	3.84615384615385	0.0340564291742691	0.146129556325616	1	1	0.99600186002898	0.99600186002898	1
up	NR1I2; CYP2A6; CYP2C9; NOS1; CYP2C19; CYP2F1; CYP2C18; CYP2A7; CYP2G1P;	GO:0042738~exogenous drug catabolic process	9	25	36	0.0350451272934363	1	1	1	1	1	1
down	CLDN3; CLDN1; RBP4; TNC; ACTC1;	GO:0045471~response to ethanol	5	100	5	0.0351057811732225	0.150350040342996	1	1	0.99600186002898	0.99600186002898	1
up	FMO2; CYP2F1; CYP2C19; CYP2A7; CYP2A6; CYP2C9; CYP2G1P; CYP2C18;	GO:0006082~organic acid metabolic process	8	21	38.0952380952381	0.0363446229223311	1	1	1	1	1	1
up	CYP2C9; CYP2C19; CYP4A11; CYP2G1P; CYP2A7; CYP2F1; CYP2C18; CYP2A6;	GO:0019373~epoxygenase P450 pathway	8	21	38.0952380952381	0.0363446229223311	1	1	1	1	1	1
up	APOA1; IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.0368674400683608	1	1	1	1	1	1
up	CCL21; IGF1; CCL19;	GO:0010560~positive regulation of glycoprotein biosynthetic process	3	3	100	0.0369563599065236	1	1	1	1	1	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021912~regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification	3	3	100	0.0369563599065236	1	1	1	1	1	1
up	AIRE; S100A8; S100A9;	GO:0032602~chemokine production	3	3	100	0.0369563599065236	1	1	1	1	1	1
up	TGM1; TGM3; HRNR;	GO:0043163~cell envelope organization	3	3	100	0.0369563599065236	1	1	1	1	1	1
up	SLIT3; SLIT2; ROBO2;	GO:0061364~apoptotic process involved in luteolysis	3	3	100	0.0369563599065236	1	1	1	1	1	1
up	MYO7B; ANKS4B; USH1C;	GO:1904970~brush border assembly	3	3	100	0.0369563599065236	1	1	1	1	1	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0369563599065236	1	1	1	1	1	1
down	MELTF; ROS1; KAZALD1; PAPPA2;	GO:0001558~regulation of cell growth	4	69	5.79710144927536	0.0370780678666549	0.155949410017584	1	1	0.99600186002898	0.99600186002898	1
down	HMGA2; TGFB2; FOXF2;	GO:0001837~epithelial to mesenchymal transition	3	40	7.5	0.0374847048158564	0.155949410017584	1	1	0.99600186002898	0.99600186002898	1
down	NTRK1; REG1A; FGF21;	GO:0031667~response to nutrient levels	3	40	7.5	0.0374847048158564	0.155949410017584	1	1	0.99600186002898	0.99600186002898	1
down	IGF2; TNC; LOX; DLX5; SFRP1;	GO:0001649~osteoblast differentiation	5	106	4.71698113207547	0.0429303538753152	0.162407556516306	1	1	0.99600186002898	0.99600186002898	1
down	CCL24; FLT4; PRKD1; CCL26;	GO:0001938~positive regulation of endothelial cell proliferation	4	73	5.47945205479452	0.0437351955158196	0.162407556516306	1	1	0.99600186002898	0.99600186002898	1
down	CDH3; PKP2; CDH26;	GO:0007043~cell-cell junction assembly	3	43	6.97674418604651	0.0444185686037767	0.162407556516306	1	1	0.99600186002898	0.99600186002898	1
down	FOXE1; SIX1; SIX4;	GO:0048538~thymus development	3	44	6.81818181818182	0.0468615795419964	0.162407556516306	1	1	0.99600186002898	0.99600186002898	1
down	MDK; CNTN1; FOXC2; HES7; SUSD5;	GO:0007219~Notch signaling pathway	5	109	4.58715596330275	0.047204812411483	0.162407556516306	1	1	0.99600186002898	0.99600186002898	1
down	NKX2-8; PDX1; PCSK9; RARB;	GO:0001889~liver development	4	75	5.33333333333333	0.0472986936942026	0.162407556516306	1	1	0.99600186002898	0.99600186002898	1
down	NTRK1; NTRK2; ATOH7; PPARGC1A;	GO:0007623~circadian rhythm	4	75	5.33333333333333	0.0472986936942026	0.162407556516306	1	1	0.99600186002898	0.99600186002898	1
up	APOA1; APOE; APOC3; LPL; CETP; GCKR; GPIHBP1; ANGPTL4; APOA4;	GO:0070328~triglyceride homeostasis	9	27	33.3333333333333	0.0490292884857544	1	1	1	1	1	1
down	ALOX15; KAZALD1; FOXC2; SOST;	GO:0001503~ossification	4	76	5.26315789473684	0.0491390267894735	0.162407556516306	1	1	0.99600186002898	0.99600186002898	1
down	DPEP1; TGFB2; CCL26; CCL24;	GO:0030593~neutrophil chemotaxis	4	76	5.26315789473684	0.0491390267894735	0.162407556516306	1	1	0.99600186002898	0.99600186002898	1
down	FOXE1; L1CAM; TGFB2; FAT1; MISP; SIX2; LAMB3; LAMA3;	GO:0016477~cell migration	8	225	3.55555555555556	0.0492981850619737	0.162407556516306	1	1	0.99600186002898	0.99600186002898	1
down	FBP2; RBP4; PPARGC1A;	GO:0006094~gluconeogenesis	3	45	6.66666666666667	0.0493694477980464	0.162407556516306	1	1	0.99600186002898	0.99600186002898	1
down	DSCAM; MDK; TNC;	GO:0007162~negative regulation of cell adhesion	3	45	6.66666666666667	0.0493694477980464	0.162407556516306	1	1	0.99600186002898	0.99600186002898	1
down	CDH16; CDH26; CDH3;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	3	45	6.66666666666667	0.0493694477980464	0.162407556516306	1	1	0.99600186002898	0.99600186002898	1
down	NKX2-8; FOSL1; PAX3; HOXD13; LHX1; PDX1; ALX1; HLF; BATF3;	GO:0006366~transcription by RNA polymerase II	9	266	3.38345864661654	0.0495009911965409	0.162407556516306	1	1	0.99600186002898	0.99600186002898	1
